Our meta-analysis indicated that CRP polymorphisms are not significantly associated with MetS (OR = 0.92, 95% CI = 0.77–1.10) with significant heterogeneity (I2 = 55.4%;p-value = 0.008). Here, CRP is linked to metabolic syndrome.